WuXi Biologics Cayman : Continues Strong Business Momentum for Sustainable High Growth in 2022
WuXi Biologics Continues Strong Business Momentum for Sustainable High Growth in 2022 Recap from the Fourth Investor Day On June ...
Read moreWuXi Biologics Continues Strong Business Momentum for Sustainable High Growth in 2022 Recap from the Fourth Investor Day On June ...
Read moreBanner Year for Commercial Manufacturing Revenue Increased by 83.3% Y-o-Y to RMB10,290.1 Million Gross Profit Increased by 90.6% Y-o-Y to ...
Read moreHong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong ...
Read moreHong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong ...
Read moreRevenue Increases by 126.7% Y-o-Y to RMB4,406.8 Million Gross Profit Grows by 191.7% Y-o-Y to RMB2,296.8 MillionAdjusted Net Profit Attributable ...
Read moreRevenue Up 45.7% Year-Over-Year to RMB10,537 MillionNet Profit Attributable to Owners of the Company Up 55.8% Year-Over-Year to RMB2,675 MillionDiluted ...
Read moreAntibody-drug conjugates are rushing to the fore. Of 11 ADCs on the market today, six have been approved since 2019. ...
Read moreWuXi Biologics reports that a joint venture company named WuXi XDC was established to provide end-to-end contract development and manufacturing ...
Read moreWuXi Biologics and WuXi STA have established a joint venture company named WuXi XDC to provide contract development and manufacturing ...
Read moreWe publish a comprehensive news feed covering all news relevant to the crypto user, covering main industry news, politics and regulation as well as consumer-level “news you can use” (practical stuff), including handy DIY tips, links to useful tools, unbiased reviews and opinions revolving around cryptocurrency. Simple logic and real-world examples are preferred before technical jargon and personal rants.